These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8831774)

  • 1. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
    Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
    J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
    Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
    J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of novel calpain inhibitors in preventing renal cell death.
    Harriman JF; Waters-Williams S; Chu DL; Powers JC; Schnellmann RG
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1083-7. PubMed ID: 10945863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors.
    Ovat A; Li ZZ; Hampton CY; Asress SA; Fernández FM; Glass JD; Powers JC
    J Med Chem; 2010 Sep; 53(17):6326-36. PubMed ID: 20690647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses and SH-enzyme inhibitory activities of new epoxysuccinic acid piperazine derivatives against mu-calpain and cathepsin B.
    Inoue J; Yoshida Y; Nakamura M; Cui YS; Nagao Y
    Drug Des Discov; 1999 Aug; 16(2):165-9. PubMed ID: 10533812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors.
    Lee KS; Seo SH; Lee YH; Kim HD; Son MH; Chung BY; Lee JY; Jin C; Lee YS
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2857-60. PubMed ID: 15911268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel series of urea-based peptidomimetic calpain inhibitors.
    Sanders ML; Donkor IO
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1965-8. PubMed ID: 16412635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enormously active and selective azapeptide inhibitor of cathepsin B.
    Wieczerzak E; Rodziewicz-Motowidło S; Jankowska E; Giełdoń A; Ciarkowski J
    J Pept Sci; 2007 Aug; 13(8):536-43. PubMed ID: 17617796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins.
    Sasaki T; Kishi M; Saito M; Tanaka T; Higuchi N; Kominami E; Katunuma N; Murachi T
    J Enzyme Inhib; 1990; 3(3):195-201. PubMed ID: 2079636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics.
    Donkor IO; Korukonda R; Huang TL; LeCour L
    Bioorg Med Chem Lett; 2003 Mar; 13(5):783-4. PubMed ID: 12617890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel piperidine carboxamide derived calpain inhibitors.
    Lubisch W; Hofmann HP; Treiber HJ; Möller A
    Bioorg Med Chem Lett; 2000 Oct; 10(19):2187-91. PubMed ID: 11012026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors.
    Dókus LE; Menyhárd DK; Tantos Á; Hudecz F; Bánóczi Z
    Eur J Med Chem; 2014 Jul; 82():274-80. PubMed ID: 24915003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, calpain inhibitory activity, and cytotoxicity of P2-substituted proline and thiaproline peptidyl aldehydes and peptidyl alpha-ketoamides.
    Korukonda R; Guan N; Dalton JT; Liu J; Donkor IO
    J Med Chem; 2006 Aug; 49(17):5282-90. PubMed ID: 16913717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel cell-penetrating alpha-keto-amide calpain inhibitors as potential treatment for muscular dystrophy.
    Lescop C; Herzner H; Siendt H; Bolliger R; Henneböhle M; Weyermann P; Briguet A; Courdier-Fruh I; Erb M; Foster M; Meier T; Magyar JP; von Sprecher A
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5176-81. PubMed ID: 16185867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, molecular modeling studies, and calpain inhibitory activity of novel alpha-ketoamides incorporating polar residues at the P1'-position.
    Donkor IO; Han J; Zheng X
    J Med Chem; 2004 Jan; 47(1):72-9. PubMed ID: 14695821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
    Xing R; Hanzlik RP
    J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
    Crawford C; Mason RW; Wikstrom P; Shaw E
    Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New m-calpain substrate-based azapeptide inhibitors.
    Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
    J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.